Skip to main content

$0.040 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
17 May 2025 at 8:21am
Register to track AC8 and receive email alerts.
Subject
AC8 Ann: Final Director's Interest Notice - C. Mews

AC8 Ann: Initial Director's Interest Notice - B. Mitchell

AC8 Ann: Appointment of Independent Non-Executive Director

AC8 Ann: Settlement of Wangara Facility

AC8 Ann: March 2023 Quarterly Activities and Cashflow Reports

AC8 Ann: Wangara Facility Sale

AC8 Ann: AusCann to Partially Divest Animal Health Assets

AC8 Ann: Appendix 4D and Half-Year Financial Report 31 December 2022

AC8 Ann: December 2022 Quarterly Activities and Cashflow Reports

AC8 Ann: Final Director's Interest Notice

AC8 Ann: Resignation of Non-Executive Director

AC8 Ann: Results of Annual General Meeting

AC8 Ann: Market Update for Shareholders

AC8 Ann: September 2022 Quarterly Activities and Cashflow Reports

AC8 Ann: Notice of Annual General Meeting/Proxy Form

AC8 Ann: Letter to Shareholders - Notice of Annual General Meeting

AC8 Ann: Annual Report

AC8 Ann: Annual Financial Statements

AC8 Ann: Appendix 4G and Corporate Governance Statement

AC8 Ann: 2022 Annual General Meeting - Key Dates

AC8 Ann: Resignation of Chief Executive Officer

AC8 Ann: Increase to EuroCann Facility & Sale of Wangara Premises

AC8 Ann: Suspension from Official Quotation

AC8 Ann: Appendix 4E

AC8 Ann: Appointment of CFO

AC8 Ann: June 2022 Quarterly Activities and Cashflow Reports

AC8 Ann: March 2022 Quarterly Activities and Cashflow Reports

AC8 Ann: AusCann to Expand into European Cannabis Market

AC8 Ann: Notification of cessation of securities - AC8

AC8 Ann: Resignation of Chief Financial Officer

AC8 Ann: Appendix 4D and Half-Year Financial Report 31 December 2021

AC8 Ann: Notification regarding unquoted securities - AC8

AC8 Ann: AusCann Receives Positive MOC from the U.S. FDA for CPAT-01

AC8 Ann: December 2021 Quarterly Activities and Cashflow Reports

AC8 Ann: AusCann Advances DermaCann Registration & US Launch

AC8 Ann: Initial Director's Interest Notice - T. McGrouther

AC8 Ann: Final Director's Interest Notice x 2

AC8 Ann: Appointment of New Chairperson and Director Resignations

AC8 Ann: AusCann Completes Successful Meeting with the U.S. FDA

AC8 Ann: Final Director's Interest Notice x 2

AC8 Ann: AusCann Board Changes

AC8 Ann: Results of Annual General Meeting

AC8 Ann: Annual General Meeting - CEO Presentation

AC8 Ann: Annual General Meeting - Chairman's Address

AC8 Ann: AusCann to Commence Cannabinoid Trial in Spinal Cord Injury

AC8 Ann: Change of Director's Interest Notice - K. Bates

AC8 Ann: Quarterly Cashflow and Market Update September 2021

AC8 Ann: AusCann Requests Formal Meeting with the FDA-CVM for CPAT-01

AC8 Ann: Annual Report

AC8 Ann: Letter to Shareholders - Notice of Annual General Meeting

Register to track AC8 and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL